Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research.


Journal

JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 18 10 2021
pubmed: 19 10 2021
medline: 3 11 2021
Statut: ppublish

Résumé

The international pediatric oncology community has a long history of research collaboration. In the United States, the 2019 launch of the Children's Cancer Data Initiative puts the focus on developing a rich and robust data ecosystem for pediatric oncology. In this spirit, we present here our experience in constructing the Pediatric Cancer Data Commons (PCDC) to highlight the significance of this effort in fighting pediatric cancer and improving outcomes and to provide essential information to those creating resources in other disease areas. The University of Chicago's PCDC team has worked with the international research community since 2015 to build data commons for children's cancers. We identified six critical features of successful data commons design and implementation: (1) establish the need for a data commons, (2) develop and deploy the technical infrastructure, (3) establish and implement governance, (4) make the data commons platform easy and intuitive for researchers, (5) socialize the data commons and create working knowledge and expertise in the research community, and (6) plan for longevity and sustainability. Data commons are critical to conducting research on large patient cohorts that will ultimately lead to improved outcomes for children with cancer. There is value in connecting high-quality clinical and phenotype data to external sources of data such as genomic, proteomics, and imaging data. Next steps for the PCDC include creating an informed and invested data-sharing culture, developing sustainable methods of data collection and sharing, standardizing genetic biomarker reporting, incorporating radiologic and molecular analysis data, and building models for electronic patient consent. The methods and processes described here can be extended to any clinical area and provide a blueprint for others wishing to develop similar resources.

Identifiants

pubmed: 34662145
doi: 10.1200/CCI.21.00075
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034-1043

Auteurs

Alejandro Plana (A)

Department of Pediatrics, University of Chicago, Chicago, IL.

Brian Furner (B)

Center for Research Informatics, University of Chicago, Chicago, IL.

Monica Palese (M)

Department of Pediatrics, University of Chicago, Chicago, IL.

Nicole Dussault (N)

Pritzker School of Medicine, University of Chicago, Chicago, IL.

Suzi Birz (S)

Department of Pediatrics, University of Chicago, Chicago, IL.

Luca Graglia (L)

Department of Pediatrics, University of Chicago, Chicago, IL.

Maura Kush (M)

Department of Pediatrics, University of Chicago, Chicago, IL.

James Nicholson (J)

Department of Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Stefanie Hecker-Nolting (S)

Klinikum Stuttgart-Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin; Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Stuttgart Cancer Center, Stuttgart, Germany.

Nathalie Gaspar (N)

Département of Oncology for Child and Adolescent, Gustave Roussy, Villejuif, France.

Mareike Rasche (M)

Department of Pediatric Hematology-Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany.

Gianni Bisogno (G)

Maternal and Child Health Department, Padua University Hospital, Padua, Italy.

Dirk Reinhardt (D)

Department of Pediatric Hematology-Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany.

C Michel Zwaan (CM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Ewa Koscielniak (E)

Klinikum Stuttgart-Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin; Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Stuttgart Cancer Center, Stuttgart, Germany.
University of Tuebingen, Tuebingen, Germany.

A Lindsay Frazier (AL)

Department of Pediatrics, Harvard University, Dana Farber Cancer Institute, Boston, MA.

Katherine Janeway (K)

Department of Pediatrics, Harvard University, Dana Farber Cancer Institute, Boston, MA.

Douglas S Hawkins (D)

Seattle Children's Hospital, University of Washington, Seattle, WA.

E Anders Kolb (EA)

Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE.

Susan L Cohn (SL)

Department of Pediatrics, University of Chicago, Chicago, IL.

Andrew D J Pearson (ADJ)

Division of Clinical Studies, Institute of Cancer Research, Royal Marsden Hospital, Sutton, United Kingdom.
retired.

Samuel L Volchenboum (SL)

Department of Pediatrics, University of Chicago, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH